
Inverness buys 76% of Standard Diagnostics for KRW242bn
Executive Summary
Deal Industry
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
-
Medical Devices
- Monitoring Equipment & Devices
-
In Vitro Diagnostics
- Biosensors
- Chemistry, Immunoassay
- Glucose Testing
- Urine-based Testing
Deal Status
- Final
Deal Type
-
Acquisition
- Partial Acquisition
- Payment Includes Cash
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com